Bridge City Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,469
Closed -$331K 101
2023
Q2
$331K Buy
13,469
+5
+0% +$161 0.16% 94
2023
Q1
$547K Sell
13,464
-48
-0.4% -$1.99K 0.27% 91
2022
Q4
$607K Sell
13,512
-96
-0.7% -$4.35K 0.31% 92
2022
Q3
$651K Buy
13,608
+460
+3% +$25.2K 0.36% 91
2022
Q2
$778K Sell
13,148
-23
-0.2% -$1.89K 0.41% 90
2022
Q1
$1.53M Sell
13,171
-64
-0.5% -$7.47K 0.72% 71
2021
Q4
$1.99M Sell
13,235
-6,101
-32% -$823K 0.82% 65
2021
Q3
$2.31M Sell
19,336
-5,148
-21% -$567K 1.05% 40
2021
Q2
$2.38M Sell
24,484
-810
-3% -$72.2K 0.81% 61
2021
Q1
$2.23M Sell
25,294
-261
-1% -$24.3K 0.74% 71
2020
Q4
$2.44M Sell
25,555
-266
-1% -$27.4K 0.93% 52
2020
Q3
$2.93M Sell
25,821
-2,503
-9% -$263K 1.4% 27
2020
Q2
$2.8M Sell
28,324
-4,323
-13% -$345K 1.29% 29
2020
Q1
$2.1M Buy
32,647
+4,178
+15% +$293K 1.02% 45
2019
Q4
$1.7M Buy
+28,469
New +$1.76M 0.7% 69

Other funds holding TNDM

Bridge City Capital's TNDM Position: Q3 2023 in Review

Bridge City Capital sold out of Tandem Diabetes Care (TNDM) in Q3 2023, closing a stake of 13,469 shares — an estimated $331K sold.

Bridge City Capital first reported a position in TNDM in Q4 2019 and held it in 15 quarters. The position peaked at $2.93M in Q3 2020. 226 funds tracked by Wall St. Rank hold TNDM as of Q3 2023.

  • Bridge City Capital reported no remaining Tandem Diabetes Care position as of Q3 2023 after selling out during the quarter.
  • Bridge City Capital sold 13,469 Tandem Diabetes Care shares in Q3 2023, an estimated $331K.
  • Bridge City Capital first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 15 quarters.
  • Bridge City Capital's Tandem Diabetes Care position peaked at $2.93M in Q3 2020.
  • 226 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2023.

Based on Bridge City Capital's 13F filing for Q3 2023, filed 15 Nov 2023.